DK136157C - - Google Patents
Info
- Publication number
- DK136157C DK136157C DK328673A DK328673A DK136157C DK 136157 C DK136157 C DK 136157C DK 328673 A DK328673 A DK 328673A DK 328673 A DK328673 A DK 328673A DK 136157 C DK136157 C DK 136157C
- Authority
- DK
- Denmark
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2811872A GB1434919A (en) | 1972-06-15 | 1972-06-15 | 3alpha-hydroxy androstanes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK136157B DK136157B (da) | 1977-08-22 |
| DK136157C true DK136157C (da) | 1978-01-23 |
Family
ID=10270562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK328673AA DK136157B (da) | 1972-06-15 | 1973-06-14 | Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-17beta-karboxylsyrederivater af androstanrækken eller salte deraf. |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE800899R (da) |
| CA (1) | CA1040619A (da) |
| DE (1) | DE2330342A1 (da) |
| DK (1) | DK136157B (da) |
| FR (1) | FR2189034B2 (da) |
| GB (1) | GB1434919A (da) |
| LU (1) | LU67790A1 (da) |
| NL (1) | NL7308267A (da) |
| ZA (1) | ZA734037B (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT202100509T1 (it) | 2013-04-17 | 2021-11-12 | Sage Therapeutics Inc | Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia |
| CN117304245A (zh) | 2013-04-17 | 2023-12-29 | 萨奇治疗股份有限公司 | 刺激神经活性的19-去甲类固醇及其使用方法 |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| US9725481B2 (en) | 2013-04-17 | 2017-08-08 | Sage Therapeutics, Inc. | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof |
| CA2918735C (en) | 2013-07-19 | 2023-08-01 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| CN105579043B (zh) | 2013-08-23 | 2021-09-14 | 萨奇治疗股份有限公司 | 神经活性类固醇、组合物和其用途 |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| US20170233433A1 (en) | 2014-10-16 | 2017-08-17 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| MY190408A (en) | 2014-10-16 | 2022-04-21 | Sage Therapeutics Inc | Compositions and methods for treating cns disorders |
| WO2016082789A1 (en) | 2014-11-27 | 2016-06-02 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| LT3250210T (lt) | 2015-01-26 | 2021-04-12 | Sage Therapeutics, Inc. | Kompozicijos ir būdai, skirti gydyti cns sutrikimus |
| DK3258939T3 (da) | 2015-02-20 | 2022-12-12 | Sage Therapeutics Inc | Neuroaktive steroider, sammensætninger og anvendelser heraf |
| WO2018013613A1 (en) | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| CA3030420C (en) | 2016-07-11 | 2025-11-18 | Sage Therapeutics, Inc. | C7, C12 AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND ASSOCIATED METHODS OF USE |
| JP7670626B2 (ja) | 2019-05-31 | 2025-04-30 | セージ セラピューティクス， インコーポレイテッド | 神経刺激性ステロイド及びその組成物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH273860A (de) * | 1942-04-25 | 1951-02-28 | Nv Organon | Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe. |
| CH616691A5 (en) * | 1970-12-17 | 1980-04-15 | Glaxo Lab Ltd | Process for the preparation of steroid compounds and their use. |
| GB1380246A (en) * | 1970-12-17 | 1975-01-08 | Glaxo Lab Ltd | 3alpha-hydroxy-androstanes and esters thereof |
-
1972
- 1972-06-15 GB GB2811872A patent/GB1434919A/en not_active Expired
-
1973
- 1973-06-14 FR FR7321743A patent/FR2189034B2/fr not_active Expired
- 1973-06-14 BE BE132254A patent/BE800899R/xx active
- 1973-06-14 NL NL7308267A patent/NL7308267A/xx not_active Application Discontinuation
- 1973-06-14 LU LU67790A patent/LU67790A1/xx unknown
- 1973-06-14 DE DE2330342A patent/DE2330342A1/de not_active Ceased
- 1973-06-14 DK DK328673AA patent/DK136157B/da unknown
- 1973-06-14 CA CA174,050A patent/CA1040619A/en not_active Expired
- 1973-06-14 ZA ZA734037A patent/ZA734037B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1040619A (en) | 1978-10-17 |
| ZA734037B (en) | 1974-05-29 |
| NL7308267A (da) | 1973-12-18 |
| LU67790A1 (da) | 1973-08-16 |
| BE800899R (fr) | 1973-12-14 |
| FR2189034A2 (da) | 1974-01-25 |
| AU5693773A (en) | 1974-12-19 |
| DE2330342A1 (de) | 1974-01-17 |
| GB1434919A (en) | 1976-05-12 |
| FR2189034B2 (da) | 1977-01-21 |
| DK136157B (da) | 1977-08-22 |